Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma

Giulia Orsi¹, Francesco Tovoli^{2

3}, Vincenzo Dadduzio⁴, Caterina Vivaldi^{5

6}, Oronzo Brunetti⁷, Luca Ielasi^{2

3}, Fabio Conti⁸, Giulia Rovesti¹, Laura Gramantieri⁹, Mario Domenico Rizzato^{4

10}, Irene Pecora⁵, Antonella Argentiero⁷, Federica Teglia^{2

3}, Sara Lonardi⁴, Francesca Salani⁵, Alessandro Granito^{2

3}, Vittorina Zagonel⁴, Giorgia Marisi¹¹, Giuseppe Cabibbo¹², Francesco Giuseppe Foschi⁸, Francesca Benevento², Alessandro Cucchetti², Fabio Piscaglia^{2

3}, Stefano Cascinu^{13

14}, Mario Scartozzi¹⁵, Andrea Casadei-Gardini^{16

17}

Affiliations

¹ Department of Oncology and Hematology, Division of Oncology, University Hospital of Modena, Via del Pozzo 71, Modena, Italy.
² Department of Medical and Surgical Sciences-DIMEC, Alma Mater Studiorum-University of Bologna, Bologna, Italy.
³ Division of Internal Medicine, Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy.
⁴ Medical Oncology Unit 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto, IRCCS, Padua, Italy.
⁵ Division of Medical Oncology 2, Pisa University Hospital, Pisa, Italy.
⁶ Department of Translational Research and New Surgical and Medical Technologies, University of Pisa, Via Savi 6, 56126, Pisa, Italy.
⁷ Medical Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
⁸ Department of Internal Medicine, Faenza Hospital, AUSL Romagna, Faenza, Italy.
⁹ Center for Applied Biomedical Research (CRBa), St. Orsola-Malpighi University Hospital, Bologna, Italy.
¹⁰ Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy.
¹¹ Biosciences Laboratory, Istituto Scientifco Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, Italy.
¹² Section of Gastroenterology and Hepatology, PROMISE, University of Palermo, Palermo, Italy.
¹³ Vita-Salute San Rafaele University, Milan, Italy.
¹⁴ Department of Medical Oncology, San Rafaele Scientifc Institute IRCCS, Milan, Italy.
¹⁵ Department of Medical Oncology, University Hospital of Cagliari, Cagliari, Italy.
¹⁶ Vita-Salute San Rafaele University, Milan, Italy. casadeigardini@gmail.com.
¹⁷ Department of Medical Oncology, San Rafaele Scientifc Institute IRCCS, Milan, Italy. casadeigardini@gmail.com.

PMID: 33113041
DOI: 10.1007/s11523-020-00765-3

Published Erratum

Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma

Giulia Orsi et al. Target Oncol. 2020 Dec.

. 2020 Dec;15(6):809-810.

doi: 10.1007/s11523-020-00765-3.

Authors

Affiliations

¹ Department of Oncology and Hematology, Division of Oncology, University Hospital of Modena, Via del Pozzo 71, Modena, Italy.
² Department of Medical and Surgical Sciences-DIMEC, Alma Mater Studiorum-University of Bologna, Bologna, Italy.
³ Division of Internal Medicine, Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy.
⁴ Medical Oncology Unit 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto, IRCCS, Padua, Italy.
⁵ Division of Medical Oncology 2, Pisa University Hospital, Pisa, Italy.
⁶ Department of Translational Research and New Surgical and Medical Technologies, University of Pisa, Via Savi 6, 56126, Pisa, Italy.
⁷ Medical Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
⁸ Department of Internal Medicine, Faenza Hospital, AUSL Romagna, Faenza, Italy.
⁹ Center for Applied Biomedical Research (CRBa), St. Orsola-Malpighi University Hospital, Bologna, Italy.
¹⁰ Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy.
¹¹ Biosciences Laboratory, Istituto Scientifco Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, Italy.
¹² Section of Gastroenterology and Hepatology, PROMISE, University of Palermo, Palermo, Italy.
¹³ Vita-Salute San Rafaele University, Milan, Italy.
¹⁴ Department of Medical Oncology, San Rafaele Scientifc Institute IRCCS, Milan, Italy.
¹⁵ Department of Medical Oncology, University Hospital of Cagliari, Cagliari, Italy.
¹⁶ Vita-Salute San Rafaele University, Milan, Italy. casadeigardini@gmail.com.
¹⁷ Department of Medical Oncology, San Rafaele Scientifc Institute IRCCS, Milan, Italy. casadeigardini@gmail.com.

PMID: 33113041
DOI: 10.1007/s11523-020-00765-3

Abstract

An Online First version of this article was made available online at https://link.springer.com/article/10.1007/s11523-020-00757-3 on 12 October 2020. Errors were subsequently identified in the article, and the following corrections should be noted.

PubMed Disclaimer

Erratum for

Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma.
Orsi G, Tovoli F, Dadduzio V, Vivaldi C, Brunetti O, Ielasi L, Conti F, Rovesti G, Gramantieri L, Rizzato MD, Pecora I, Argentiero A, Teglia F, Lonardi S, Salani F, Granito A, Zagonel V, Marisi G, Cabibbo G, Foschi FG, Benevento F, Cucchetti A, Piscaglia F, Cascinu S, Scartozzi M, Casadei-Gardini A. Orsi G, et al. Target Oncol. 2020 Dec;15(6):773-785. doi: 10.1007/s11523-020-00757-3. Target Oncol. 2020. PMID: 33044683

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma

Affiliations

Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources